ACR/ARHP 2018 Annual Meeting
CVD Risk Reduced in Rheumatoid Arthritis Treated With Methotrexate and bDMARDs
A reduction in risk for cardiovascular disease has been reported among patients with rheumatoid arthritis who are receiving concomitant therapy with methotrexate and biologic disease-modifying antirheumatic drugs.